SFM CEO Exercises Options and Sells Shares at ~$102 Average
Rhea-AI Filing Summary
Jack L. Sinclair, CEO and Director of Sprouts Farmers Market (SFM), reported option exercises and sales under a Rule 10b5-1 plan. On 10/06/2025 and 10/07/2025 he exercised a total of 8,090 stock options with an exercise price of $16.47 and simultaneously sold the same number of shares under a prearranged trading plan at weighted-average prices of approximately $102.9986 and $101.4674. After these transactions he beneficially owned 174,740 shares, including 38,573 restricted stock units that vest on scheduled dates in 2026, 2027, and 2028. The filing discloses the sales were made pursuant to a 10b5-1 plan and that all exercised options were presently exercisable.
Positive
- Sales conducted under a Rule 10b5-1 plan provide procedural compliance and reduce concerns about opportunistic timing
- Options exercised were deeply in-the-money (strike $16.47 vs sale prices ~$101–$105), indicating strong realized gain for the insider
- Restricted stock units retain staggered vesting through 2028, supporting ongoing executive alignment with shareholders
Negative
- Insider reduced direct holdings to 174,740 shares, which lowers the executive's immediate equity stake
- 38,573 RSUs vest over 2026–2028, representing potential near-term dilution and additional shares that could be sold when vested
Insights
Insider exercised options then sold shares under a 10b5-1 plan, reducing direct holdings to 174,740 shares.
The reporting person exercised 8,090 options at an exercise price of $16.47 on 10/06/2025 and 10/07/2025, creating no immediate cash cost beyond exercise but realizing proceeds by selling the underlying shares under a Rule 10b5-1 plan at weighted-average prices near $102.
This sequence is a common liquidity action for executives: it converts option upside into cash while following a pre-established trading plan to mitigate insider-trading concerns. Monitor the remaining 38,573 RSUs with vesting through 2028 for potential future dilution and any additional scheduled sales under the plan within the next 12–24 months.
Exercise-to-sell reflects typical option monetization; vesting schedule preserves retention linkage.
The options exercised had a low strike of $16.47 relative to sale prices near $101–$105, implying material intrinsic value was realized. The filing shows all such options were exercisable and the seller used a 10b5-1 plan to execute sales across multiple trade prices.
Key items to track include the vesting of 11,556, 15,194, and 11,823 RSUs on specified dates in 2026–2028, which may increase share count and create future sellable stock for the insider over the next 24–36 months.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) | 4,045 | $0.00 | $0.00 |
| Exercise | Common Stock, par value $0.001 per share | 4,045 | $16.47 | $67K |
| Sale | Common Stock, par value $0.001 per share | 4,045 | $101.4674 | $410K |
| Exercise | Stock Option (right to buy) | 4,045 | $0.00 | $0.00 |
| Exercise | Common Stock, par value $0.001 per share | 4,045 | $16.47 | $67K |
| Sale | Common Stock, par value $0.001 per share | 4,045 | $102.9986 | $417K |
Footnotes (5)
- F1. This transaction was pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.74 to $105.04 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.105 to $102.930 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4. Includes 136,167 shares of common stock and 38,573 restricted stock units. Each restricted stock unit represents the right to receive, upon vesting, one share of common stock. 11,556 restricted stock units will vest on March 14, 2026, 15,194 restricted stock units will vest evenly over two years on March 19, 2026 and March 19, 2027 and 11,823 restricted stock units will vest evenly over three years on March 12, 2026, March 12, 2027 and March 12, 2028. All such vests assume continued employment through the applicable vest date.
- F5. All such options are presently exercisable.
AI-generated analysis. How Rhea-AI works. Not financial advice.